• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during breastfeeding and pregnancy is challenging for women with the condition. Little data exists about how long-term exposure to these medications could affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological developmental disorders like hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication must evaluate the benefits of using it against the possible risks to the baby. Physicians don't have the data needed to make unequivocal recommendations however they can provide information about risks and benefits that assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy did not have a greater risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based case control study to compare the incidence of major structural defects in infants who were born to mothers who used stimulants during pregnancy. Clinical geneticists and pediatric cardiologists reviewed the cases to ensure accurate case classification and to limit the chance of bias.

However, the study had its limitations. Researchers were unable to, in the first place, to separate the effects of the medication from the disorder. That limitation makes it difficult to know whether the limited associations observed in the groups that were exposed are due to the use of medication or the confounding effect of comorbidities. Additionally the researchers did not look at long-term offspring outcomes.

The study did reveal that infants whose mothers took ADHD medication during pregnancy were at a higher risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or stopped their medications before or during pregnancy. This was due to central nervous system-related disorders, and the higher risk of admission was not found to be influenced by which stimulant medication was used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an increased chance of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases didn't seem to be influenced by the kind of medication used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medications during early pregnancies could be offset by the greater benefits to both mother and baby from continuing treatment for the woman's disorder. Physicians should speak with their patients about this and as much as possible, assist them develop coping strategies that may reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

Many doctors are confronted with the dilemma of whether to maintain treatment or stop as more women are diagnosed with ADHD. Often, these decisions are made without any evidence that is clear and definitive either way, so physicians must weigh their knowledge, the experiences of other doctors, and what medications are prescribed for adhd research suggests about the subject, along with their best judgment for each patient.

The issue of risk to infants is particularly tricky. Many studies on this issue are based on observational evidence rather than controlled research, and their conclusions are often contradictory. In addition, most studies limit their analysis to live births, which could underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study discussed in this journal club addresses these issues by looking at data from both live and deceased births.

Conclusion Some studies have revealed an association between ADHD medications and certain birth defects However, other studies haven't established a link. most popular adhd medication (Recommended Online site) studies have shown an unintended, or slight negative effect. In all cases it is imperative to conduct a thorough evaluation of the benefits and risks must be performed.

For many women with ADHD and ADD, the decision to stop medication can be difficult, if not impossible. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. A decrease in medication could affect the ability to drive safely and to perform work-related tasks which are essential aspects of everyday life for people with ADHD.

She recommends women who are uncertain about whether to keep or stop medication in light of their pregnancy consider educating family members, friends and colleagues about the condition, its impact on daily functioning, and the advantages of staying on the current treatment regimen. It can also make the woman feel more comfortable as she struggles with her decision. Some medications can pass through the placenta. If the patient decides not to take her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be transferred to the infant.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns about what impact the drugs might have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this subject. Using two massive data sets, researchers were able to examine more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of certain heart defects, such as ventriculoseptal defect (VSD).

The authors of the study found no link between the use of early medications and other congenital anomalies, like facial clefting, or club foot. The results are in line with previous studies showing the presence of a small, but significant increase in the risk of developing cardiac malformations among women who started taking ADHD medications prior to the time of pregnancy. The risk increased in the latter half of pregnancy when many women stopped taking their medication.

Women who were taking intuniv adhd medication medication during the first trimester were more likely require a caesarean delivery, have a low Apgar after delivery and have a baby who needed help breathing after birth. However, the authors of the study were not able to eliminate selection bias by limiting the study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope that their research will help doctors when they see pregnant women. They suggest that although discussing the risks and benefits is crucial however, the decision to stop or keep treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors warn that, although stopping the medication is a possibility to look into, it is not recommended due to the high rate depression and other mental problems in women who are expecting or who have recently given birth. Further, research shows that women who stop taking their medication will have a difficult adjustment to life without them after the baby is born.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women with ADHD who have to deal with their symptoms while attending physician appointments and getting ready for the arrival of a baby and adapting to new routines in the home may face a lot of challenges. As such, many women choose to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant drugs are absorbed by breast milk in small quantities, so the risk for nursing infant is very low. The rate of medication for adhd and depression exposure can vary depending upon the dosage the medication is administered, its frequency and the time of the day. Additionally, individual medications enter the baby's system differently through the gastrointestinal tract and breast milk. The impact of this on a newborn infant is not yet fully understood.

Due to the absence of evidence, some doctors might be tempted to stop taking stimulant medication during a woman's pregnancy. It is a difficult decision for the mother, who must weigh the benefits of continuing her medication against the risks to the embryo. As long as more information is available, GPs can a doctor prescribe adhd medication inquire about pregnant patients whether they have any background of ADHD or if they plan to take medication in the perinatal period.

Numerous studies have demonstrated that women can continue to take their ADHD medication in a safe manner during pregnancy and breast-feeding. In the end, more and more patients are choosing to do so, and after consulting with their doctor, they have found that the benefits of continuing their current medication far outweigh any potential risks.

Women who suffer from ADHD who plan to breastfeed should seek advice from an expert psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continuing treatment, including non medication treatment for adhd adults-pharmacological strategies. Psychoeducation should also be provided to help pregnant people with ADHD recognize their symptoms and underlying disorder, learn about available treatments and to reinforce existing strategies for managing. This should be a multidisciplinary process including obstetricians, GPs, and psychiatrists. Pregnancy counseling should include a discussion of a treatment plan for the mother and child, and monitoring for signs of deterioration and, if needed adjustments to the medication regimen.